FDA Grants Breakthrough Device Status to Toku's Patented Cardiovascular Risk AI (CLAiR) Platform
Press Release Toku, Inc., a commercial medical device company specializing in imaging technology and AI, announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation to its patented CLAiR technology. The CLAiR platform, if…
Source: venturebeat.com